. Shepard and others (1955) and Bates and others (1956) have shown that, while both ventilation and diffusing capacity are usually impaired in emphysema, the impairment may affect either one or other of these tests of function disproportionately. As was noted by Donald and others (1952) , reduction of the gas-blood interface by tissue destruction, and impairment of distribution of inspired air by airway obstruction, may both contribute to impairment of the diffusing capacity. The proportionate responsibility of these two factors is, however, unknown. Little has been published on the diffusing capacity in asthma. Bates (1952) measured the percentage uptake of carbon monoxide in 13 young asthmatics aged 12-19 years and found an abnormally low figure in only one. Ogilvie and others (1957) mention one asthmatic patient whose diffusing capacity was normal.
The objects of the present investigation were to examine the effects of two drugs, isoprenaline given by inhalation and prednisone orally, on the ventilation and diffusing capacity in patients with asthma and emphysema, and to attempt to assess the degree to which airway obstruction can depress the diffusing capacity in these disorders. The bronchodilator action of isoprenaline is well established (Rossier, 1949; Gilson and HughJones, 1955) , and the beneficial action of prednisone in asthma, and occasionally in emphysema, has been mentioned above.
SELECTION OF PATIENTS
All the subjects of this investigation suffered from asthma or emphysema. Most gave a history of wheezing, but a few were incluided in whom there was no such history although ventilatory tests showed evidence of airway obstruction. In patients classified as asthmatic the dyspnoea and wheezing were intermittent, though four were included in whom the breathlessness, previously intermittent, had become constant in recent months. In a few infective cases chronic bronchitis was also present with sputum containing bacterial pathogens, but in general bronchitis was not a dominant symptom. At least one of the following features was also usually found: a family history of asthma, a history of other allergic disorders such as paroxysmal rhinorrhoea, hay fever, or nasal polypi, and eosinophilia in the blood or sputum. Slight.-Prolonged expiration, scattered rhonchi. It is to be noted that airway obstruction severe enough to cause dyspnoea at rest may be present without any wheeze, the only auscultatory sign sometimes being weak breath sounds. Patients in status asthmaticus were excluded from the investigation because they were too ill to carry out the tests. METHODS The ventilatory test selected was the forced expiratory volume at one second (Gaensler, 1951) , because it gives information equivalent to that provided by the maximal ventilatory volume and is less exhausting for the patient. Now generally known as the FEV,, it was measured on the spirogram obtained from a spirometer of the type described by Bernstein, D'Silva, and Mendel (1952) at a peripheral drum speed of 16 mm. per second (Gandevia, Hume, and Prime, 1957) . The mean was taken of three satisfactory tracings.
The diffusing capacity for carbon monoxide (DL) was estimated by the steady-state technique of Bates and others (1955) on a simplified circuit devised by Prime (MacNamara, Prime, and Sinclair, 1959) . This method is based on the assumption that the CO tension of the end-tidal sample is equivalent to the mean alveolar CO tension. The DL is then calculated by dividing this figure into the rate of uptake of CO and is expressed as ml./min./mm. Hg. However, in normal subjects, as Bates points out, the end-tidal CO tension is likely to be lower than the mean alveolar CO tension, and the value for DL will be correspondingly high. In patients with an uneven distribution of inspired air, such as is found in asthma and emphysema, the end-tidal CO tension may be higher or lower than the mean alveolar CO tension, and the magnitude of the error thus introduced cannot be known. Duplicate estimations of DL showed surprisingly good agreement in the present series even in the presence of moderately severe airway obstruction, suggesting that the error due to uneven distribution does not vary greatly over short periods. Although the method of Filley and others (1954) The dosage of prednisone is described later.
RESULTS
ISOPRENALINE. -Forty -seven patients were investigated, 38 men and nine women. There were no essential differences in the results as between the sexes. Twelve patients, eight men and four women, were certainly asthmatics. All the remainder are classified below as cases of chronic bronchitis and emphysema, although in six (two men and four women) there was doubt as to the group in which they should be placed. At the time of testing wheezing was moderately severe in four, moderate in 14, slight in 14, and absent in 15 patients. Among the last group wheezing had been present in the recent past in 10 and had not been observed at any time in five. The effects on FEV1 and D, will be described separately. A. Effect on FEV1.-The results shown in Table I are divided into two groups according to the magnitude of the response to isoprenaline, an increase of 25% being taken as the arbitrary dividing line. The mean increase in FEV1 was greater in the asthmatic patients in each group, though there was a very wide scatter around the means. The most important point shown in Table I is the absence of any significant increase in mean DL even when there was a significant improvement in FEV1 after isoprenaline. Table II shows that younger patients responded better than-older, the reason being that eight of the nine patients under the age of 41 were asthmatics. The response in relation to the severity of wheezing is shown in Table III . The best results were obtained in those patients with slight or moderate wheezing, and these two groups included 10 of the 12 asthmatics. In the severe group there was one asthmatic, a girl aged 24 years with long-standing infective asthma, who, in spite of marked airway obstruction (FEV1 415 ml.) which responded poorly to isoprenaline, had a normal DL of 15 ml./min./ mm. Hg. With the exception of one asthmatic boy aged 17 years who was free from bronchospasm on the day of the test and responded with an increase in FEV1 of less than 25%, all the patients with no wheezing, i.e., the " nil " group in Table III , were suffering from chronic bronchitis and varying degrees of emphysema. In only one was the increase in FEVI impressive in absolute terms, a man aged 38 years who had been breathless on exertion for 11 years and wheezed only in foggy weather. His FEV1 increased from 965 ml. to 1,360 ml. and he was thus the only patient in the series who had no auscultatory signs of bronchospasm and showed a large increase in FEV1 after isoprenaline.
The results confirm the bronchodilator action of isoprenaline. Its comparative failure in the severe group suggests that part of the airway obstruction was due to some mechanism other than bronchospasm, or that isoprenaline as given in this investigation was not powerful enough to release severe bronchospasm.
B. Effect on DL.-That there is a relationship between FEV1 and DL is shown in Fig. 1 , where the values for log FEV1 and for DL before treatment are plotted for each of 63 patients with asthma or chronic bronchitis and emphysema. It will be seen that when the FEV1 is low the DL is likely also to be low. In view of this it might be expected that an increase in DL would occur after isoprenaline in those patients whose FEV1 improves considerably, but there is no indication of this in Table I . With such a wide scatter around the means, however, a real correlation might be concealed. Therefore, in Fig. 2 DL after isoprenaline for all 47 patients. It is clear that there is no correlation, and this is equally true of asthmatics and of patients suffering from chronic bronchitis and emphysema. Because MacNamara, Prime, and Sinclair (1959) have shown a direct relationship between minute volume and DL at rest, the percentage changes in these values after isoprenaline for all 47 patients were plotted in Fig. 3 , from which it is evident that there is a highly significant degree of correlation. There is no evidence that isoprenaline, under the conditions of the present investigation, has any consistent action on the minute volume, over a sufficient number of patients. PREDNISONE. Prednisone was given to 13 patients and corticotrophin to one, in whom routine antispasmodics had failed to give adequate relief. All had a history of wheezing at some time. Cases 1-5, 10, 13, and probably 14 (see Table IV and below) were asthmatics, and the remainder were suffering from chronic bronchitis and severe emphysema. When steroid treatment was begun wheezing was moderate in Cases 2, 3, 13, and 14, absent in Cases 11 and 12, both of which were, however, very breathless on exertion, and in the remainder was severe. Before in which an increase in DL is accompanied by a proportionate increase in minute volume, and those in which the minute volume remains substantially unchanged or even falls. The former association, first noted by MacNamara, Prime, and Sinclair (1959) , is found to occur regularly with the present technique of estimating DL. The reason for this increase is not altogether clear, but presumably, as in exercise, hyperventilation is bringing into use the respiratory reserve. When, however, for the same minute volume a much greater quantity of gas is transferred from the inspired air into the blood, a real improvement in lung function is clearly implied. Such is the case in those patients whose DL improves on prednisone.
The reason for the failure of isoprenaline to increase the DL when it produces an increase in FEVI is not clear. There seems to be no obvious explanation in the pharmacology of isoprenaline, which is said to cause brief vasodilatation and more prolonged tachycardia with an increase in the cardiac output (Dautrebande, 1952; Sollmann, 1957) . If the cardiac output rises it is difficult to envisage any general pulmonary vasoconstriction which might reduce the gas-blood interface and thus decrease the uptake of CO. (Long and Favour, 1950 ; Carey, Harvey, Howard, and Winkenwerder, 1950) . Reports regarding its effect on the immediate, histamine type of sensitivity reaction, however, remain conflicting. Goth, Allman, Merritt, and Holman (1951) found that injecting dogs with the surface-active agent Tween 20 caused a liberation of histamine from the tissues and a consequent fall in blood pressure, and this effect was repeated with further injections of the same substance. Cortisone did not prevent the fall in blood pressure after the first dose of Tween 20, but did prevent a fall after a second dose. The authors interpreted these findings as evidence that cortisone is unable to counteract the effects of histamine already formed in the tissues, but that it prevents the synthesis of further histamine. Schayer, Davis, and Smiley (1955) found that rat skin, when incubated with 14C L-histidine, converted a small percentage to 14C histamine which remained in a bound condition in the skin. Pre-treatment of the rats with cortisone impaired this conversion. Lovell, Goodman, Hudson, Armitage, and Pickering (1953) , in a series of experiments in man, confirmed the suppressive action of cortisone on the delayed type of sensitivity reaction, but concluded that it had little or no effect on the immediate skin reaction to histamine. Holti (1956) has criticized the work of Lovell and others, on the grounds that they measured weals only up to 10 minutes after pricks with histamine solution, and that they did not compare prick tests at identical skin temperatures. Holti made careful measurements of weals 10 and 20 minutes after pricking histamine solutions into the skin, with strict control of skin temperature, and showed that oral cortisone. while its effect after 10 minutes was slight, exerted a clear-cut suppressive action at 20 minutes. This effect was more evident with large doses of cortisone. These findings may have some bearing on the mode of action of cortico-steroids in asthma, though it must be admitted that antihistamines have little effect in asthma.
While in the present series the history was of value in forecasting the likely response to prednisone, the auscultatory signs differed little in character or severity as between successes and failures. A good response to prednisone seemed more likely in patients whose FEV1 increased by over 25% after isoprenaline.
The action of prednisone on the DL in asthmatics is evidence that airway obstruction can depress the diffusing capacity. By analogy, in cases of emphysema, although reduction of the capillary bed by tissue destruction is no doubt one important factor in impairment of the DL, it seems probable that airway obstruction also plays a significant part. It is of interest that as long ago as 1925 Beitzke, on the basis of histological examination of normal and emphysematous lungs, together with experiments on the mixing of plain and coloured water by to-and-fro piston action in glass tubes of different shapes, suggested that the impairment of gas exchange in emphysema was due less to reduction of the alveolar surface area than to poor mixing of inspired and alevolar air.
Two final points may be noted in connexion with the response to prednisone. In Cases 6 and 11, although there was little clinical improvement and the FEV1 remained substantially unchanged, the DL increased significantly, suggesting that improved ventilation may not be the whole explanation of the action of prednisone. The results in Case 14 show that when moderate doses of prednisone fail to abolish bronchospasm, a short course with a heavy dosage may succeed, and the spasm may thereafter be controlled by a small maintenance dose.
CONCLUSIONS
In 47 patients with asthma or emphysema, isoprenaline, even when it caused a considerable increase in the forced expiratory volume at one second (FEV1), did not increase the diffusing capacity for carbon monoxide (DL), changes in which were associated with unpredictable changes in minute volume.
Prednisone or corticotrophin caused clinical and objective improvement in six asthmatics, but had little effect on one case of long-standing infective asthma and on seven cases of chronic bronchitis and emphysema. In patients responding well, a pronounced increase in DL occurred, associated with a considerable increase in FEV1 and without any proportionate change in minute volume.
Bronchospasm can markedly depress the DL A normal DL may, however, be found in association with moderately severe bronchospasm.
In assessing the significance of changes in DL at rest, the minute volume must be taken into account ; a proportionate change in minute volume considerably reduces the significance of any alteration in DL.
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